24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
27/06/2017
Barcelona Synchrotron Park’s sustainable brownfield restoration program presented at AquaConSoil 2017
21/06/2017
Catalonia confirms itself as pole of attraction for foreign investments
15/06/2017
Construction of the Natura Bissé’s new world headquarters is well on its way
06/06/2017
Walk in the Park: the biodiversity routes await you
31/05/2017
UAB second most innovative university in Spain
24/05/2017
PRUAB: 10 years in strengthening relationships between research and business fabric